ReviewFrontiers in oncology2021

Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

Konstantinos Liapis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.